Πέμπτη 18 Ιανουαρίου 2018

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.

Related Articles

The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer.

Future Oncol. 2018 Jan 16;:

Authors: Santana-Davila R, Chow LQ

PMID: 29334785 [PubMed - as supplied by publisher]



from #PM All via ola Kala on Inoreader http://ift.tt/2mRSbPo

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου